Clinical Trial

To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 13, 2026 (before its estimated June 25, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to compare efficacy of methotrexate vs apremilast in the management of chronic plaque psoriasis.Given the high prevalence of psoriasis in Pakistan and the significant psychological impact on patients, particularly in Peshawer,this study will provide valuable insights into optimal treatment strategies.
Trial Details
NCT Number NCT07337434
Lead Sponsor Syeda Sana Zaman
Conditions Chronic Plaque Psoriasis
Enrollment 106 participants
Start Date 2025-12-25
Primary Completion 2026-06-25 (estimated)
Study Completion 2026-06-25 (estimated)
Updated on ClinicalTrials.gov 2026-01-13